{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:49Z","timestamp":1786118749928,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/01.inf.0000259955.66171.0c","type":"journal-article","created":{"date-parts":[[2007,4,23]],"date-time":"2007-04-23T04:03:18Z","timestamp":1177300998000},"page":"387-392","source":"Crossref","is-referenced-by-count":3,"title":["Immunologic Considerations for the Timing of the Booster Dose of 7-Valent Pneumococcal Conjugate Vaccine in Young Children"],"prefix":"10.1097","volume":"26","author":[{"given":"David W.","family":"Scheifele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Ochnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Mozel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denzyl","family":"Duarte-Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wortzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"RR-9","key":"R1-5-20210202","first-page":"1","article-title":"Prevention of pneumococcal disease among infants and young children.","volume":"49","year":"2000","journal-title":"Morb Mort Wk Rep"},{"key":"R2-5-20210202","first-page":"1","article-title":"Statement on recommended use of pneumococcal conjugate vaccine.","volume":"28","year":"2002","journal-title":"Can Commun Dis Rep"},{"key":"R3-5-20210202","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00006454-200004000-00035","article-title":"Immunogenicity of pneumococcal conjugate vaccines.","volume":"19","author":"Eskola","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00006454-199906000-00015","article-title":"Pneumococcal conjugate vaccines.","volume":"18","author":"Eskola","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics"},{"key":"R6-5-20210202","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-199909000-00004","article-title":"Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.","volume":"18","author":"Shinefield","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R7-5-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children.","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R8-5-20210202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0264-410X(97)80914-0","article-title":"Antibody titers eight months after three doses of a five-valent pneumococcal conjugate vaccine in HIV and non-HIV-infected children less than two years of age.","volume":"16","author":"King","year":"1998","journal-title":"Vaccine"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0264-410X(98)00232-1","article-title":"A comparative study of PENTATM vaccine booster doses given at 12, 15 or 18 months of age.","volume":"17","author":"Scheifele","year":"1999","journal-title":"Vaccine"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0264-410X(01)00028-7","article-title":"Neonatal and early life vaccinology.","volume":"19","author":"Siegrist","year":"2001","journal-title":"Vaccine"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.vaccine.2005.11.021","article-title":"Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP. IPV\/PRP-T Hib and hepatitis B vaccines in infants 2\u20137 months of age.","volume":"24","author":"Scheifele","year":"2006","journal-title":"Vaccine"},{"key":"R13-5-20210202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Post-licensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends in invasive disease due to Streptococcus pneumoniae among children in the Intermountain West: emergence of non-vaccine groups.","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1503\/cmaj.051150","article-title":"Progress in the prevention of pneumococcal infection.","volume":"173","author":"Kellner","year":"2005","journal-title":"Can Med Assoc J"},{"key":"R17-5-20210202","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1086\/322794","article-title":"Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children.","volume":"184","author":"Soininen","year":"2001","journal-title":"J Infect Dis"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1086\/431679","article-title":"Serum serotype-specific pneumococcal anti-capsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.","volume":"192","author":"Dagan","year":"2005","journal-title":"J Infect Dis"},{"key":"R19-5-20210202","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.inf.0000187030.83080.8a","article-title":"Nasopharyngeal colonization with heptavalent pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae with prolonged vaccine dosing intervals.","volume":"24","author":"Jones","year":"2005","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200705000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:37:14Z","timestamp":1786034234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200705000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000259955.66171.0c","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}